ID
30271
Description
Study of Blood and Tissue Samples in Predicting Response to Second-Line Therapy Using Erlotinib Hydrochloride or Chemotherapy in Patients With Advanced Non-Small Cell Lung Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT00989690
Lien
https://clinicaltrials.gov/show/NCT00989690
Mots-clés
Versions (1)
- 26/05/2018 26/05/2018 -
Détendeur de droits
See clinicaltrials.gov
Téléchargé le
26 mai 2018
DOI
Pour une demande vous connecter.
Licence
Creative Commons BY 4.0
Modèle Commentaires :
Ici, vous pouvez faire des commentaires sur le modèle. À partir des bulles de texte, vous pouvez laisser des commentaires spécifiques sur les groupes Item et les Item.
Groupe Item commentaires pour :
Item commentaires pour :
Vous devez être connecté pour pouvoir télécharger des formulaires. Veuillez vous connecter ou s’inscrire gratuitement.
Eligibility Lung Cancer NCT00989690
Eligibility Lung Cancer NCT00989690
- StudyEvent: Eligibility
Similar models
Eligibility Lung Cancer NCT00989690
- StudyEvent: Eligibility
C0205179 (UMLS CUI [1,2])
C3258246 (UMLS CUI [1,3])
C1999216 (UMLS CUI [1,2])
C1708063 (UMLS CUI [2,1])
C0007131 (UMLS CUI [2,2])
C0205179 (UMLS CUI [2,3])
C0220650 (UMLS CUI [1,2])
C0205318 (UMLS CUI [1,3])
C0494165 (UMLS CUI [2])
C0201899 (UMLS CUI [2])
C0494165 (UMLS CUI [3])
C0332197 (UMLS CUI [1,2])
C0006147 (UMLS CUI [2,1])
C0332197 (UMLS CUI [2,2])
C1404410 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C2945640 (UMLS CUI [2,3])
C0036043 (UMLS CUI [2,4])
C0018801 (UMLS CUI [3])
C0035078 (UMLS CUI [4])
C0031117 (UMLS CUI [5])
C1707251 (UMLS CUI [2])
C1705847 (UMLS CUI [3,1])
C0007117 (UMLS CUI [3,2])
C0282313 (UMLS CUI [4,1])
C1514873 (UMLS CUI [4,2])
C0392920 (UMLS CUI [4,3])
C0205156 (UMLS CUI [1,2])
C0279134 (UMLS CUI [2])